Xenter, Inc. raises $58.25 million in Series B financing to accelerate the commercial launch of its TechMed platform. This funding will also support innovation in wireless medical devices and technologies.
Amount Raised
$58.3 Million
Round Type
Series B
DraperBiotechnologyHealthcareDescription
Xenter, Inc., a leader in healthcare intelligence, successfully closed its Series B financing on June 30th, raising a total of $58.25 million. The round included existing shareholders and prominent healthcare investors. The funds will be used for commercial launch, technology development, and regulatory initiatives for Xenter's TechMed platform. This financing underlines the growing interest in Xenter's capabilities in capturing and utilizing healthcare data.
Quick answer
XENTER raised $58.3 Million in a Series B round, dated July 16, 2026. XENTER is based in Draper, Utah, United States.
- How much did XENTER raise?
- XENTER raised $58.3 Million in a Series B round on July 16, 2026.
- What does XENTER do?
- Xenter™ has launched a wireless “Technology in Medicine” (TechMed) ecosystem that is designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, & patients.
- Where is XENTER based and how big is it?
- XENTER is based in Draper, Utah, United States. Fundz records about 9 employees.
- Who are the decision-makers at XENTER?
- Fundz holds 3 contacts at XENTER, including the Vice President Marketing. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as XENTER that raised within 45 days of this round, from Fundz verified event records.
- Tenon Medical raised $3M (Post-IPO Equity) on August 28, 2026.
- Endovia Health Sciences, Inc. raised $108K (Funding Round) on August 28, 2026.
- BioLineRx Ltd raised $3.8M on August 27, 2026.
- Amylyx Pharmaceuticals raised $500M (Post-IPO Equity) on August 20, 2026.
- HeartSciences raised $1M (Post-IPO Equity) on August 19, 2026.
- Daré Bioscience, Inc. raised $6M (Post-IPO Equity) on August 14, 2026.
Who to call at XENTER, and when
A new round usually means XENTER is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day XENTER raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at XENTER, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at XENTER. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment XENTER raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansXENTER raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.